Close
Back to KMPH Stock Lookup

KemPharm (KMPH) – Major News

Nov 9, 2022 04:23 PM KemPharm (KMPH) Reports In-Line Q3 EPS
Aug 11, 2022 04:59 PM KemPharm (KMPH) Misses Q2 EPS by 56c
Feb 23, 2018 02:01 PM KemPharm (KMPH) Reports FDA Approval of Apadaz for Short-Term Management of Acute Pain
Jun 13, 2016 04:16 PM KemPharm (KMPH) Receives FDA Complete Response Letter for Apadaz NDA
May 12, 2016 04:47 PM KemPharm (KMPH) Tops Q1 EPS by 26c
May 5, 2016 05:17 PM KemPharm (KMPH) Receives Mixed FDA Panel Vote on Apadaz; Issues Commentary
Mar 10, 2016 03:51 PM KemPharm (KMPH) Misses Q4 EPS by 14c
Nov 12, 2015 04:45 PM KemPharm (KMPH) Misses Q3 EPS by 26c
Oct 21, 2015 04:29 PM KemPharm (KMPH) Says Clinical Trial Reaffirms Properties of KP201/APAP
Aug 13, 2015 04:09 PM KemPharm (KMPH) Reports Q2 Loss Per Share of $2.45
Aug 13, 2015 04:07 PM KemPharm (KMPH) Reports Positive Data From Intranasal Human Abuse Liability Study of KP201/APAP
Apr 16, 2015 10:51 AM KemPharm (KMPH) IPO Opens Up 7%

Back to KMPH Stock Lookup